title: Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome.
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Giovannini
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Tendas
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Alessio
authors.initials: A
authors.lastname: Perrotti
authors.affiliation: Haematology Unit, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: De Fabritiis
mesh_terms: D000368:Aged; D000753:Anemia, Refractory / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D002872:Chromosome Deletion; D002890:Chromosomes, Human, Pair 20 / Q000648:ultrastructure; D002999:Clone Cells / Q000473:pathology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction; D028761:Withholding Treatment
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa